Is Formycon AG halal to invest in?

According to Musaffa's Shariah screening methodology, Formycon AG (FYB.DE) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Formycon AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Formycon AG using these criteria to determine its compliance status.

Can Muslims buy shares of Formycon AG?

Muslim investors may consider investing in Formycon AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Formycon AG classified as HALAL?

Musaffa determines the Shariah status of Formycon AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Formycon AG updated?

The Shariah compliance status of Formycon AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Formycon AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Formycon AG?

You can check the latest Shariah compliance status of Formycon AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Formycon AG FYB.DE

€17.92 €1.04 (5.49%) 1D

Last Updated: May 04, 12:00 AM·XETRA

FYB.DE Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: October 14, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Formycon AG (FYB.DE)

Based on 15 analysts giving stock ratings to Formycon AG in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Formycon AG. Stock Analysis FYB.DE

Germany Health Care Small Cap Report: Q2, 2025

Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 245 full-time employees. The company went IPO on 2010-12-20. The firm is engaged in providing biosimilar drugs and formulations. The firm focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Key Statistics of Formycon AG (FYB.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€17.52€18.02

Today's Open

€18.96

Volume

22.26K

P/E Ratio (TTM)

52 Week Range

€15.80€31.30

Market Cap

406.48M

Avg. Volume

3068.20

Dividend Yield

Financial Metrics & Statements of Formycon AG (FYB.DE)

FAQ's for Formycon AG (FYB.DE)

According to Musaffa’s Shariah screening methodology, Formycon AG (FYB.DE) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Related Halal Stocks to Formycon AG (FYB.DE)

Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.

	Name	Price	1D Change	Market Cap	Rating
	Medigene AG MDG1.DE	€0.13	14.15%	€1.32M	Unlock